In this issue: PhyMatrix Will Focus on Clinical Trials Industry, PRA International IPO Remains on Hold, Quarterly Reports, INDs up 6% in 1997, Covalent Group Gets $5 Million Contract, The CenterWatch Index, Financial News, Industry Briefs, Personnel, Drug Pipeline News and Trial Results